Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GISAA trial of ginkgolide injection plus aspirin in large-artery atherosclerotic ischemic stroke
ChiCTR-IPR-17012310Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Ginkgolide and aspirin in ischemic stroke (2 arms), sponsored by Huashan Hospital. Primary endpoints: Recurrence rate and mortality rate of ischemic stroke and National Institutes of Health Stroke Scale score. Started Jul 2016; status: recruiting.
02
Drugs
Ginkgolideaspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-IPR-17012310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012310.